Management costs | Cost (€) | Source |
Statins (Atorvastina 20 MG 28 comprimidos) | 120.14 | https://botplusweb.portalfarma.com/botplus.aspx Botplus 2015 |
Aspirin (Adiro 100 mg 30 comprimidos) | 88.27 | https://botplusweb.portalfarma.com/botplus.aspx Botplus 2015 |
ACE inhibitor (Enalapril 20 MG 28 comprimidos) | 21.00 | https://botplusweb.portalfarma.com/botplus.aspx Botplus 2015 |
Annual Screening for microalbuminurea | 50.83 | eSalud 2015 (official tariff) |
Annual screening gross renal protenuira | 203.44 | eSalud 2015 (official tariff) |
Stopping ACEs due to side effects | 54.08 | [21] Fonseca 2013 |
Annual eye screening | 55.27 | eSalud 2015 (official tariff) |
Foot screening program | 23.69 | eSalud 2015 (official tariff) |
Non-standard ulcer treat (eg. Regranex) | – | |
Anti-depression treatment | 288.05 | [22] Salvador-Carulla 2009 |
Screening for depression | – | eSalud 2015 (official tariff) |
Direct costs CVD complications | Cost (€) | Source |
Myocardial infarction 1st year average | 5282.63 | [23] Abad 2015 |
Myocardial infarction 1st year fatal | 4566.21 | [23] Abad 2015 |
Myocardial infarction 1st year non-fatal | 5383.13 | [23] Abad 2015 |
Myocardial infarction 2nd + years | 860.43 | [23] Abad 2015 |
Angina 1st year | 2373.60 | [23] Abad 2015 |
Angina 2nd + years | 860.43 | [23] Abad 2015 |
Congestive heart failure 1st year average | 3564.34 | [23] Abad 2015 |
Congestive heart failure 1st year fatal | 4566.21 | [23] Abad 2015 |
Congestive heart failure 1st year non-fatal | 3505.02 | [23] Abad 2015 |
Congestive heart failure 2nd plus years | 3554.47 | [23] Abad 2015 |
Stroke 1st year non-fatal | 6658.42 | [23] Abad 2015 |
Stroke 2nd + years | 3595.02 | [23] Abad 2015 |
Stroke death within 30 days | 4566.21 | [23] Abad 2015 |
Peripheral vascular disease 1st year | 2373.60 | [23] Abad 2015 |
Peripheral vascular disease 2nd + years | 860.43 | [23] Abad 2015 |
Direct costs renal complications | Cost (€) | Source |
Haemodialysis 1st year | 47,069.14 | [24] Villa 2011 |
Haemodialysis 2+ years | 43,997.16 | [24] Villa 2011 |
Peritoneal dialysis 1st year | 32,022.17 | [24] Villa 2011 |
Peritoneal dialysis 2+ years | 29,927.06 | [24] Villa 2011 |
Renal transplant costs 1st year | 51,677.66 | [24] Villa 2011 |
Renal transplant 2+ years | 7280.71 | [24] Villa 2011 |
Direct costs acute events | Cost (€) | Source |
Major hypoglycaemic event | 1038.23 | [25] Hammer 2009 |
Minor hypoglycaemic event | 59.07 | [25] Hammer 2009 |
Lactic acid event | 3446.53 | Ministry of Health 2012 |
Edema onset (adverse event) | 5225.52 | Ministry of Health 2012 |
Edema follow-up (adverse event) | – | |
Direct costs acute events | Cost (€) | Source |
Laser treatment | 126.84 | eSalud 2015 (official tariff) |
Cataract operation | 1006.63 | eSalud 2015 (official tariff) |
Following cataract operation | 52.32 | Tarifas CCAA 2008. |
Blindness - year of onset | 1875.14 | [23] Abad 2015 |
Blindness - following years | 805.05 | [23] Abad 2015 |
Direct costs acute events | Cost (€) | Source |
Neuropathy, 1st year | 4653.06 | [26] Rodríguez 2011 |
Neuropathy, 2nd + years | 4653.06 | [26] Rodríguez 2011 |
Amputation (event based) | 3644.47 | [23] Abad 2015 |
Amputation Prosthesis (event based) | 3712.05 | Estimation |
Gangrene treatment | 10,131.19 | eSalud 2015 (official tariff) |
After healed ulcer | – | |
Infected ulcer | 5042.78 | eSalud 2015 (official tariff) |
Standard uninfected ulcer | 1120.96 | eSalud 2015 (official tariff) |
Healed ulcer history of amputation | – |